deliv one core pillar thesi improv organ growth
howev overshadow signific margin compress
expect continu result ebitda guid
come expect wasnt enough dividend
slash took impair charg disclos sec investig
organ sale growth solid trend expect continu
better balanc vol/mix/pric compar organ sale
growth came combin w/ growth repres best
organ growth least last year organ sale growth driven
pt volum partial off-set pt price/mix manag expect posit organ
growth expect price posit net key commod price
price turn posit margin trend stabil sentiment may turn posit
believ pure penalti box
profit much weaker expect lead signific profit
miss disappoint ebitda guidanc margin much weaker
expect rel estim gross margin miss bp sg a/sal bp
higher expect result ebit margin miss estim bp result
ebit miss estim consensu led us
acceler commerci invest suppli chain inflat lower expect
cost save compress margin moreov manag guid ebitda
impli anoth bp declin margin m/p ebitda guidanc
set estim
perform improv materi like remain justifi
penalti box especi given dividend cut impair charg ebitda
miss estim last quarter ebitda estim
reduc last two year manag argu much
shortfal expect come fx headwind step invest
 inflat net cost save come higher expect investor believ
compani overearn disappoint ebitda result impair charg
point strongli although compani posit dividend cut offens
move aim de-lever quicker better posit consolid industri
model show higher leverag end rel previou estim
includ assumpt margin expans
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
assum y/i sale growth sale
grow europ row
year signific margin compress
project bp ebit margin expans driven
on-going cost save initi higher capac
util owe improv sale volum
growth owe continu invest go-to-
price target price-to-earnings multipl base
case ep estim
assum y/i sale growth sale
grow europ row
year signific margin compress
project bp ebit margin expans driven
better cost save flow increment price
higher capac util owe improv
sg a/sal come bp owe solid
top-lin growth offset invest
price target price-to-earnings multipl
upsid case ep estim
assum y/i declin sale growth
sale europ row flat
despit preced year signific margin
compress project bp ebit
margin compress driven price net
commod neg continu invest
brand build cost save run
price target price-to-earnings multipl
downsid case ep estim
expect organ sale growth sale
profit continu grow lsd line
signific option exist estim
divestitur could sourc cash use de-lev
monthli po data nielsen iri especi khc key
page
pleas see import disclosur inform page report
organ sale growth solid trend expect continu
better balanc vol/mix/pric compar organ
sale growth came combin growth repres
best organ growth least last year organ sale growth
driven pt volum partial off-set pt price/mix manag expect posit
organ growth expect price posit net key commod
price price turn posit margin trend stabil sentiment might turn posit
pure penalti box
profit much weaker expect lead signific profit
miss disappoint ebitda guidanc margin much weaker
expect rel estim gross margin miss bp sg a/sal
bp higher expect result ebit margin miss estim bp
result ebit miss estim consensu led
us acceler commerci invest suppli chain inflat lower
expect cost save compress margin moreov manag guid
ebitda impli anoth bp declin margin m/p
ebitda guidanc set estim
perform improv materi remain penalti box
right especi given dividend cut impair charg
ebitda miss estim last quarter ebitda estim
reduc last two year manag argu
much shortfal expect come fx headwind step
invest inflat net cost save come higher expect
investor believ compani overearn disappoint ebitda result
impair charg certainli point although compani posit
dividend cut offens move aim de-lever quicker better posit
consolid industri model show higher leverag end
rel previou estim includ assumpt margin expans
slash estim lower ep estim
reflect miss lower sale margin assumpt
sale estim decreas primarili account fx headwind announc
divestitur margin estim dramat lower primarili driven lower
assumpt us segment result ebitda estim
low end manag guidanc rang
incorpor dividend cut proce sale recent
announc divestitur project net debt/ebitda end
end term line item
take account manag guidanc lower y/i incom
increas interest expens
valuat updat new pt reflect price-to-earnings multipl ep
estim pt chang reflect lower earn
estim lower target multipl lower target multipl reflect view
given string disappoint earn manag lost credibl
believ transform acquisit less like
page
pleas see import disclosur inform page report
chart price-to-earnings premium/discount rel
page
pleas see import disclosur inform page report
